Resmed

We’re proud to share that Resmed has received U.S. FDA clearance for Personalized Therapy Comfort Settings (PTCS), which will be marketed as Smart Comfort —an AI-enabled medical device that personalizes CPAP therapy comfort settings for people with obstructive sleep apnea (OSA). Powered by machine learning and more than 100 million nights of real-world sleep data, Smart Comfort recommends individualized comfort settings to help people with OSA start and stay on CPAP therapy. What this means for people with OSA: -A smoother, easier start for new users -Select comfort settings tailored to each individual -Supports users in feeling more confident and engaged as they get started with therapy For healthcare providers, this means: -Easier setup and follow up -Insight that can help reduce the need for manual adjustments -More time to focus on clinical decision-making and patient care Smart Comfort will launch in a limited U.S. beta version in early 2026 for new myAir™ users with an AirSense™ 11 device, with a broader U.S. rollout planned later in the year. This milestone reflects our ongoing commitment to using technology and real-world evidence to help people sleep better, breathe better and live healthier lives. Learn more: https://lnkd.in/g9Vb8jQr #SleepHealth #HealthTech #AIinHealthcare

Resmed is proud to be an Associated Partner of the European Digital Health Summit that took place in Madrid, Spain this week, an important gathering bringing policymakers, industry, academia, and civil society together for discussions addressing Europe’s most pressing health challenges including digital health interoperability, supplies of medicines and medical devices, and cybersecurity. This is a pivotal moment for Europe’s digital transformation, and it’s especially meaningful to see these discussions take place in an EU Member State, close to where new digital health regulations are becoming reality. 🇪🇸🤝🇪🇺 Key topics on the agenda included: • AI’s role in the future of healthcare • Interoperability and secure health data flows • Policy-to-practice: scaling-up digital health While engaging with key stakeholders, Resmed featured a display of our digitally enabled solutions highlighting how connected care can support better patient care and outcomes. See our video here: https://lnkd.in/gc8WGUsP #DigitalHealth #EUHealthPolicy #Interoperability #AIinHealth #OneHealth #Resmed #EuropeanDigitalHealthSummit

📢 Scientific evidence continues to strengthen the connection between sleep health and cardiovascular outcomes - a theme that took centre stage during the European Business Summits #EHS2025 panel on December 3, “Sleep as a Vital Sign: The Cardiovascular Imperative.” Resmed’s Vice President of Health Research Dr. Kimberly Sterling joined leading cardiovascular experts and EU policymakers to highlight why sleep health needs a stronger place in Europe’s cardiovascular health strategies. She discussed new evidence showing that sleep disorders — particularly obstructive sleep apnoea (OSA) — are under-recognized drivers of cardiovascular disease. She highlighted that 40- 80% of cardiology patients may suffer from undiagnosed OSA — with even greater underdiagnosis among women — and called for EU policy to adopt appropriate guidelines and embed routine sleep screening into cardiovascular risk pathways to support earlier and more equitable detection: “Sleep disorders are modifiable cardiovascular risk factors. Screening and treating them is one of the most actionable ways Europe can reduce cardiovascular disease today.” A warm thank you to fellow panellists Prof. Gianfranco Parati, Dr. Christoph Schöbel, and Tomislav Sokol for an insightful, forward-looking discussion — and to moderator Dr. Sarah-Taïssir Bencharif, MD for guiding the conversation with expertise and clarity. 👉 Want to explore the full discussion? A recording of the session will be available on the European Health Summit website: https://lnkd.in/gGRfe-XX #EHS2025 #SleepHealth #CardiovascularHealth #DigitalHealth #Prevention #EUHealth #HealthEquity #Resmed

Schlafmedizin im Aufbruch: Eindrücke vom DGSM Kongress 2025 Danke an alle, die uns am Resmed-Messestand und in unserem Symposium „Schlafapnoe decoded“ besucht haben. Der diesjährige Kongress der Deutsche Gesellschaft für Schlafforschung und Schlafmedizin e.V. hat die Ausgestaltung der Patientenversorgung in den Mittelpunkt gestellt — und aufgezeigt, wie wichtig es ist, technische Weiterentwicklungen sinnvoll in die Praxis zu integrieren. Im Anschluss an unser Symposium haben wir Prof. Dr. Christoph Schöbel und Holger Woehrle nach ihren Takeaways gefragt: Welche Methode für welchen Patienten? Welche Evidenz brauchen wir im deutschen Versorgungskontext? Und welche Rahmenbedingungen ermöglichen nachhaltige Versorgung? Die Aufbruchsstimmung war überall spürbar. 🎥 Im Video teilen die beiden Experten ihre Eindrücke. Wir freuen uns auf das nächste Wiedersehen! #DGSM2025 #Schlafmedizin #Innovation #DigitalHealth

I’m looking forward to participating in the European Health Summit panel on Sleep as a Vital Sign: The Cardiovascular Imperative. Sleep disorders remain one of the most underestimated risks to heart health. With millions living with disrupted sleep, the need to treat sleep as a true vital sign has never been clearer. Together with Christoph Schöbel ,Prof Gianfranco Parati , Tomislav Sokol and Sarah-Taïssir Bencharif, MD we will explore how poor sleep accelerates cardiovascular disease, the important role of early detection and digital solution, and why now is the right moment to integrate sleep into Europe’s cardiovascular agenda. Through our health research at Resmed , we’re working to deepen understanding of how sleep affects long-term outcomes for people and healthcare systems – and to bring evidence that can support stronger prevention strategies across Europe. European Business Summits #EuropeanHealthSummit #SleepHealth #CardiovascularHealth #EUPolicy

📍You don’t need every step mapped out to build a meaningful career. 📍 That’s according to Alison Besley, a senior manager, transformation, global supplier alliance at Resmed. After 18 years at Resmed, Alison speaks from experience when she says that that growth often comes from staying open to change and new possibilities. 👉 Discover her top three lessons for building a long-lasting and fulfilling career: https://lnkd.in/gU27eBbd 👉 Explore open roles: https://lnkd.in/gXqX7n4X #ResmedGlobalSupplyChain #ShapeTheFuture #Resmed #LifeAtResmed #WomenInSupplyChain

This week, two of our Resmed leaders are in Brussels for a series of advocacy engagements focused on strengthening regulatory clarity, advancing digital health, and elevating sleep health in the EU's agenda. Katrin Pucknat, Chief Marketing Officer, will join strategic policy discussions — including with the Cabinet of EU Digital Commissioner, Henna Virkkunnen, DIGITALEUROPE Health Executive Council meeting with EU Health Commissioner, Oliver Varhelyi, and dinner with select European Ministers of Health — to deliberate on the future of AI, digital and medical devices regulations, and the European Health Data Space (EHDS). Dr. Kimberly Sterling, Vice President for Health Research, will participate in the European Health Summit, where she will speak on the critical role of sleep as a vital sign of cardiovascular health. She will also engage with Members of European Parliament to highlight the importance of integrating sleep health into the EU’s Cardiovascular Health Plan to enable earlier detection, reduced costs, and improved health outcomes across Europe. Learn more: https://lnkd.in/eAmjkQbZ 🤝 These engagements reflect a shared goal: Shaping a European healthcare ecosystem where digital innovation, evidence-based prevention and enabling regulation work together to improve outcomes for patients and healthcare systems. #Resmed #EUHealth #DigitalHealth #SleepHealth #CardiovascularHealth #EHDS #AIAct #MDR #HealthPolicy #NCDs

🤝 Ihr Partner auf dem Weg zu gesundem Schlaf Besuchen Sie uns auf dem DGSM-Kongress 2025 und erleben Sie, wie Resmed mit innovativen Technologien für mehr Sicherheit, Therapieakzeptanz und digitale Vernetzung in der Schlafmedizin sorgt. An unserem Messestand Nr. 14 präsentieren wir unsere 360°-Lösungen – von smarter Diagnostik über zuverlässige Therapiegeräte bis hin zu digitalen Services und der intraoralen Schlaftherapie Narval™. Erfahren Sie, wie wir Sie unterstützen, damit Ihre Patient:innen gesünder schlafen und besser leben. 👉 Nicht verpassen: Unsere heutige Industriesession von 12:00–13:30 Uhr | Glashalle Tauchen Sie ein in die Schlafmedizin aus neuen Perspektiven: „Schlafapnoe decoded – interaktiv. kontrovers. praxisnah.“ Mit Holger Woehrle und Prof. Dr. Christoph Schöbel Diskutieren Sie mit zu aktuellen Themen wie: ASV – was stimmt jetzt eigentlich? Diagnose- und Therapieeinleitung – wann sind wir bereit, uns zu verändern? Lifetime-Management – wie ist das machbar? Sie entscheiden – Ihr Thema live diskutiert! Wir freuen uns auf spannende Gespräche, neue Impulse – und auf Sie! #DGSM2025 #Schlafmedizin #Innovation #OSA #Narval #Therapieakzeptanz #DigitalHealth #360GradLösungen